Related references
Note: Only part of the references are listed.Insunn Muscle Glucos Uptake, and Hexokinase Revisiting Road Not Taken
David H. Wasserman
PHYSIOLOGY (2022)
Patients with Central Hypothyroidism are Less Sufficiently Treated with Levothyroxine than Patients with Primary Hypothyroidism
Barbara Samec et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2022)
Marsupsin Isolated from Polyherbal Product ABPA Rejuvenates Insulin Resistance in L6 Skeletal Muscle Cell Line via IRS1-PI3K-AKT-GLUT4 Signaling Pathway
Abbirami Balachandran et al.
FASEB JOURNAL (2022)
Role of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Different Disease States: Recent Updates
Suvadeep Mal et al.
CURRENT MEDICINAL CHEMISTRY (2021)
The Effect of Dual-Task Testing on Balance and Gait Performance in Adults with Type 1 or Type 2 Diabetes Mellitus: A Systematic Review
Humberto Omana et al.
CURRENT DIABETES REVIEWS (2021)
Importance of understanding the real cause of death in status epilepticus
Maximiliano A. Hawkes et al.
EPILEPSY & BEHAVIOR (2020)
Drivers for the comorbidity of type 2 diabetes mellitus and epilepsy: A scoping review
Nathan A. Shlobin et al.
EPILEPSY & BEHAVIOR (2020)
Evidence-based anti-seizure monotherapy in newly diagnosed epilepsy: A new approach
Maria Compagno Strandberg et al.
ACTA NEUROLOGICA SCANDINAVICA (2020)
Progress in the discovery of naturally occurring anti-diabetic drugs and in the identification of their molecular targets
Jian-Hua He et al.
FITOTERAPIA (2019)
Effects of antiepileptic drugs on lipogenic gene regulation and hyperlipidemia risk in Taiwan: a nationwide population-based cohort study and supporting in vitro studies
Yi-Wen Li et al.
ARCHIVES OF TOXICOLOGY (2018)
A population-based study of epilepsy incidence in association with type 2 diabetes and severe hypoglycaemia
Chin-Li Lu et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
Long-term risk of rosiglitazone on cardiovascular events - a systematic review and meta-analysis
Dayan Cheng et al.
ENDOKRYNOLOGIA POLSKA (2018)
Repurposing Valproate, Enteral Clonidine, and Phenobarbital for Comfort in Adult ICU Patients: A Literature Review with Practical Considerations
David J. Gagnon et al.
PHARMACOTHERAPY (2017)
Repurposing the anti-epileptic drug sodium valproate as an adjuvant treatment for diffuse intrinsic pontine glioma
Clare L. Killick-Cole et al.
PLOS ONE (2017)
Association between type 1 diabetes mellitus and risk of epilepsy: A meta-analysis of observational studies
Dandan Yan et al.
DRUG DISCOVERIES AND THERAPEUTICS (2017)
Serum insulin and leptin levels in children with epilepsy on valproate-associated obesity
Talha Rehman et al.
JOURNAL OF PEDIATRIC NEUROSCIENCES (2017)
Epilepsy in cerebrovascular diseases: Review of experimental and clinical data with meta-analysis of risk factors
Edoardo Ferlazzo et al.
EPILEPSIA (2016)
Diabetes and Epilepsy in Children and Adolescents
M. Loredana Marcovecchio et al.
CURRENT DIABETES REPORTS (2015)
Drug-Induced Hyperglycaemia and Diabetes
Neila Fathallah et al.
DRUG SAFETY (2015)
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPAR-γ): a review
Limei Wang et al.
BIOCHEMICAL PHARMACOLOGY (2014)
ILAE Official Report: A practical clinical definition of epilepsy
Robert S. Fisher et al.
EPILEPSIA (2014)
Population-Level Evidence for an Autoimmune Etiology of Epilepsy
Mei-Sing Ong et al.
JAMA NEUROLOGY (2014)
Valproic Acid Is a Novel Activator of AMP-Activated Protein Kinase and Decreases Liver Mass, Hepatic Fat Accumulation, and Serum Glucose in Obese Mice
Lindsay B. Avery et al.
MOLECULAR PHARMACOLOGY (2014)
Discovering New Treatments for Alzheimer's Disease by Repurposing Approved Medications
Brian S. Appleby et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
Metabolic and endocrine effects of valproic acid chronic treatment
Vincenzo Belcastro et al.
EPILEPSY RESEARCH (2013)
PPARγ signaling and metabolism: the good, the bad and the future
Maryam Ahmadian et al.
NATURE MEDICINE (2013)
EXERCISE, GLUT4, AND SKELETAL MUSCLE GLUCOSE UPTAKE
Erik A. Richter et al.
PHYSIOLOGICAL REVIEWS (2013)
Severe Hypoglycemia in a Juvenile Diabetic Rat Model: Presence and Severity of Seizures Are Associated with Mortality
Margaret Maheandiran et al.
PLOS ONE (2013)
Beta Cell Dysfunction and Insulin Resistance
Marlon E. Cerf
Frontiers in Endocrinology (2013)
Association Between Seizures and Diabetes Mellitus: A Comprehensive Review of Literature
Chen Yun et al.
CURRENT DIABETES REVIEWS (2013)
Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study
John G. Hanly et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Seizures and type 1 diabetes mellitus: current state of knowledge
Alberto Verrotti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Characterization of glucose homeostasis and lipid profile in adult, seizure-free, epileptic patients in Asian population
K. Phabphal et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Thiazolidinediones and PPARγ agonists: time for a reassessment
Bertrand Cariou et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
Molecular signatures database (MSigDB) 3.0
Arthur Liberzon et al.
BIOINFORMATICS (2011)
Systemic and neurologic autoimmune disorders associated with seizures or epilepsy
Angela Vincent et al.
EPILEPSIA (2011)
The role of valproate in metabolic disturbances in bipolar disorder patients
Hui Hua Chang et al.
JOURNAL OF AFFECTIVE DISORDERS (2010)
Adipokines as regulators of muscle metabolism and insulin sensitivity
David J. Dyck
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2009)
Antiepileptic drug utilization in Taiwan: Analysis of prescription using National Health Insurance database
Liang-Po Hsieh et al.
EPILEPSY RESEARCH (2009)
Valproate-Induced Insulin Resistance and Obesity in Children
Alberto Verrotti et al.
HORMONE RESEARCH (2009)
Effect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trial
C. K. Martin et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2009)
Decreased PPARγ Expression Compromises Perigonadal-Specific Fat Deposition and Insulin Sensitivity
Yau-Sheng Tsai et al.
MOLECULAR ENDOCRINOLOGY (2009)
Obesity is a common comorbidity for pediatric patients with untreated, newly diagnosed epilepsy
Z. S. Daniels et al.
NEUROLOGY (2009)
Transcriptional regulation of the insulin-responsive glucose transporter GLUT4 gene: from physiology to pathology
Eddy Karnieli et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
The insulin receptor:: a new anticancer target for peroxisome proliferator-activated receptor-γ (PPARγ) and thiazolidinedione-PPARγ agonists
V. Costa et al.
ENDOCRINE-RELATED CANCER (2008)
Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARγ in promoting steatosis
Jie Zhou et al.
GASTROENTEROLOGY (2008)
Valproate, weight gain and carbohydrate craving: A gender study
Firas El-Khatib et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2007)
Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report
Elinor Ben-Menachem
EPILEPSIA (2007)
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Steven E. Kahn et al.
NATURE (2006)
Characterization of insulin secretion in valproate-treated patients with epilepsy
Virpi Pylvanen et al.
EPILEPSIA (2006)
Serum insulin, leptin, and neuropeptide Y levels in epileptic children treated with valproate
K Aydin et al.
JOURNAL OF CHILD NEUROLOGY (2005)
Weight change in monozygotic twins treated with valproate
KM Klein et al.
OBESITY RESEARCH (2005)
The effects of phenytoin and its metabolite 5-(4-hydroxyphenyl)-5-phenylhydantoin on cellular glucose transport
HY Wong et al.
LIFE SCIENCES (2005)
Muscle-specific Pparg deletion causes insulin resistance
AL Hevener et al.
NATURE MEDICINE (2003)
Detailed analysis of grid-based molecular docking: A case study of CDOCKER - A CHARMm-based MD docking algorithm
GS Wu et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2003)
Insulin resistance in epileptic girls who gain weight after therapy with valproic acid
A Verrotti et al.
JOURNAL OF CHILD NEUROLOGY (2002)
GLUT4 is reduced in slow muscle fibers of type 2 diabetic patients - Is insulin resistance in type 2 diabetes a slow, type 1 fiber disease?
M Gaster et al.
DIABETES (2001)
Weight gain associated with valproate in childhood
E Demir et al.
PEDIATRIC NEUROLOGY (2000)
KEGG: Kyoto Encyclopedia of Genes and Genomes
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
